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The hepatitis B virus (HBV) genome is known to contain four conserved and overlapped open reading frames (ORFs)
encoding the viral core, polymerase (P), surface (S), and X proteins. Whether HBV encodes other proteins has long been a
major interest in the field. Using 32P-labeling of an introduced protein kinase A site attached to the N- or C-terminus of the
HBV polymerase gene, a 43-kDa P–S fusion protein was detected in cell lysate, secreted virions, and 22-nm subviral particles.
Immunobiochemical studies showed that the 43-kDa protein contains the epitopes of the N-terminus of polymerase and most
parts of the surface proteins. This 43-kDa protein was shown to be a glycoprotein, similar to the surface protein. RT-PCR and
sequence analyses identified a spliced mRNA which was derived from pregenomic RNA with a deletion of 454 nucleotides
(nt) from nt 2447 to 2902. This splice event creates a P–S fusion ORF. This finding is consistent with the result obtained from
an immunobiochemical study. Mutations at the splice donor or acceptor site on the HBV genome abrogated the production
of the 43-kDa protein. These mutants had no effect on viral replication in transfected HuH-7 cells. However, this P–S fusion
protein is able to substitute for the LS protein in virion maturation. On the basis of these results, we conclude that the 43-kDa
protein is a polymerase-surface fusion protein encoded by a spliced RNA. Similar to the LS protein, the 43-kDa P–S fusion
protein is a structural protein of HBV and might play a role in the HBV life cycle. © 2000 Academic Press
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The hepatitis B virus (HBV) is a member of the Hep-
adnaviridae, a family of small enveloped viruses with
partially double-stranded DNA genomes (for recent re-
views see Ganem, 1996; Nassal and Schaller, 1993, 1996;
and Nassal, 1996). HBV infection is a major health prob-
lem in the world, particularly in East Asia and Central
Africa, where an estimated 10% of the population are
HBV carriers and many of them die from liver cirrhosis
and hepatocellular carcinoma. The HBV genome is ap-
proximately 3200 base pairs in length and consists of
four overlapping open reading frames (ORFs) which en-
code the viral core, polymerase (P), surface (S), and X
proteins (Fig. 1A). The three surface proteins (or surface
antigens, HBsAg) are translated from a single S ORF via
hree different in-phase start codons (Fig. 1A). The small
urface antigen (SS) contains 226 amino acids. The mid-
le surface (MS) protein is extended by an additional
-terminal 55 amino acids of pre-S2 domain and the
arge surface (LS) protein by an additional 163 amino
cids of pre-S2 plus pre-S1 domain (subtype ayw, Heer-
ann et al., 1984). Part of the surface proteins are N-
lycosylated. Recent studies indicate an important rela-
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398ionship between the surface proteins and virion matu-
ation or virion infectivity (Bruss et al., 1994; Bruss and
homssen, 1994; Heermann and Gerlich, 1991; Pontisso
t al., 1989; and Le Seyec et al., 1998). However, with the
xception of a few reports (Dyson and Murray, 1995;
oisson et al., 1997), the interaction between nucleocap-
ids and the surface proteins is still poorly defined.
A unique feature of hepadnaviruses is their unusual
echanism of viral DNA replication involving reverse
ranscription of pregenomic RNA by viral encoded poly-
erase, a pivotal process similar to that of a retrovirus.
owever, there are also features unique to retroviruses
hat had not been discovered in HBV, such as: (i) all
etroviruses utilize an RNA splicing mechanism to gen-
rate the env mRNA; (ii) some retroviruses, such as
IV-1, produce several spliced RNAs to encode regula-
ory proteins (Tat, Rev, Vif, Vpr, and Nef) which are either
ssential for viral replication or capable of modulating
eplication; (iii) some retroviral proteins are produced by
osttranslational processing of polyprotein precursors
reviewed in reference to Vaishnav and Wong-Staal,
991). In general, RNA splicing, processing of polypro-
ein, and fusion proteins play important roles in the
etrovirus life cycle. Considering the evolutionary rela-
ionship between hepadnavirus and retroviruses, similar
NA and protein processing probably also occur in the
BV life cycle. Indeed, several pregenomic RNA-derived
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399A NOVEL HBV STRUCTURAL PROTEINspliced transcripts of HBV have been found in liver tis-
sues or in hepatoma cell lines transfected with cloned
HBV DNA (Chen et al., 1989; Gu¨nther et al., 1997; Su et
al., 1989; Suzuki et al., 1989, 1990; and Terre´ et al., 1991).
urthermore, these spliced RNAs contain ORFs encod-
ng various P- and S-related proteins. Recently, spliced L
NA was described in duck hepatitis B virus (DHBV) and
hown to be functional in early steps of the viral life cycle
Obert et al., 1996). More recently, a 10-kDa protein en-
oded by a singly spliced RNA was reported to be ex-
ressed in HBV-infected livers and was demonstrated to
e involved in the apoptosis process in transfected
uH-7 cells (Soussan et al., 2000). In this study, we
eport a 43-kDa polymerase and surface fusion protein
hich was encoded by a novel HBV spliced RNA. Like
FIG. 1. Detection of a 43-kDa protein associated with HBV viral part
gene of HBV. Four ORFs of HBV are shown at the top. The gray bar an
used for generating P6 and NX antisera, respectively. Plasmid pMTP0
phosphorylation sequence in P-expressing plasmids pMTP0I, pMTP0II
pMH-9/3091 by deleting a single T (nt 916). (B) A summary of methods
the 43-kDa protein from various pol-expressing plasmids by immunopr
3, 8), pMTP0III (lanes 4, 9), pMTP0 (lanes 5, 10), pMH-9/3091-II (lan
precipitated by antiserum against the HBV core protein. Resulting immu
serum (lanes 1 and 6), NX (lanes 2 to 5), or P6 (lanes 7 to 12) antisera
gain, reprecipitated by the same sera, and finally subjected to 10% S
3-kDa protein are indicated.he LS protein, this 43-kDa protein is a HBV structural pprotein incorporated into viral particles and may play a
role in the viral life cycle.
RESULTS AND DISCUSSION
Construction and detection of HBV P protein
containing the protein kinase A (PKA) target site
In order to detect the minute amount of the P or its
related proteins of HBV, a highly sensitive method used
previously for the successful detection of interferon (Li et
al., 1989) and HBV polymerase (Bartenschlager et al.,
1992) was employed. In this method, a phosphorylation
site of protein kinase A was introduced into HBV pol
ene. Subsequently, P protein or its related products
rom these constructs was labeled with 32P by PKA phos-
) Schematic representation of the PKA phosphorylation site on the P
led bar on the P ORF indicate amino acid sequences of the P protein
nstructed from pMH3/3097 (see text). Positions of the introduced PKA
MTP0III are indicated by *. Plasmid pMH-9/3091-m4 was derived from
ection of P and its related proteins (see text for detail). (C) Analysis of
tion assay. As represented in (B), pMTP0I (lanes 2, 7), pMTP0II (lanes
and pMH-9/3091 (lane 12) transfected HuH-7 cell lysates were first
ipitates were denatured by boiling, immunoprecipitated by preimmune
beled with [g-32P]ATP and PKA. Labeled 32P proteins were denatured
GE analysis. The positions of the 90-kDa full-length P protein and theicles. (A
d stipp
was co
, and p
for det
ecipita
e 11),
noprec
, and la
DS–PAhorylation in vitro. As shown in Fig. 1A, the construction
400 HUANG ET AL.of human metallothionein promoter-controlled P-expres-
sion plasmids that carry the PKA targeting sequence at
the C-terminus (pMTP0I), N-terminus (pMTP0II), and both
the N- and C-termini (pMTP0III) was similar to that de-
scribed before (Bartenschlager et al., 1992). To produce
virions carrying HBV polymerases with the PKA site, the
P-expressing plasmids (pMTP0I, pMTP0II, or pMTP0III)
were used to cotransfect HuH-7 cells with pMH-9/
3091-m4 which carries all of the functional HBV gene
products with the exception of a null mutation at the
reverse transcriptase (RT) domain of polymerase (Chiang
et al., 1990). HBV endogenous polymerase activity assay
revealed that the polymerase activity produced by
pMTP0II was not affected, in which pMTP0I was reduced
to one-quarter while pMTP0III was reduced to one-tenth
compared to wild-type pMTP0 (data not shown).
To analyze particle-associated P or its related proteins
(see flow chart of Fig. 1B), lysates or concentrated cul-
tural media from transfected HuH-7 cells were incubated
with protein A Sepharose coated with anti-core anti-
serum. After several washings, the immunoprecipitates
were boiled in sample buffer followed by dilution with 20
vol of RIPA buffer. After centrifugation, the supernatant
was immunoprecipitated again with anti-polymerase an-
tiserum. After washings with RIPA buffer and PKA buffer,
the immunoprecipitates were phosphorylated with PKA
using [g-32P]ATP as a substrate (Bartenschlager et al.,
1992). The phosphorylated immunoprecipitates were
boiled and reimmunoprecipitated with specific anti-poly-
merase antiserum. Finally, the immunoprecipitates were
subjected to 10% sodium dodecyl sulfate–polyacrylam-
ide gel electrophoresis (SDS–PAGE) and autoradiogra-
phy.
Detection of a 43-kDa protein from secreted HBV
particles
As shown in Fig. 1C, in addition to the full-length
90-kDa P protein, a considerably larger amount of dou-
blet protein with apparent molecular weight of 43 kDa
was precipitated by a P6 antiserum (Bartenschlager et
al., 1992), a polyclonal antibody that recognizes the N-
terminal 34–51 residues of the P protein, in pMTP0II- and
pMTP0III-transfected HuH-7 cell lysates (lanes 8 and 9),
but not in pMTP0- and pMTP0I-transfected cell lysates
(lanes 7 and 10). The 43-kDa band was specifically la-
beled at the introduced N-terminal PKA target site of P
protein (compares lanes 7 and 10 with lanes 8 and 9). In
addition, this 43-kDa doublet was not recognized by P8
antiserum against the C-terminal 813–832 residues of the
P protein (data not shown, Bartenschlager et al., 1992).
Thus, our results indicate that the doublet-protein spe-
cifically contains the N-terminal, but not the C-terminal,
portion of the P protein. A similar 43-kDa protein was
reported previously by Bartenschlager and Schaller
(1992) as a by-product from a transcomplementation ex-periment with plasmid expressing the P gene. Surpris-
ingly, this 43-kDa protein could not be precipitated by a
rabbit serum (NX) against the N-terminal residues 40–
372 of the P protein (Lin et al., 1993) that partially over-
laps with the C-terminus of the P6 peptide sequence (Fig.
1C, lanes 3 and 4). This suggests that the 43-kDa protein
contains the extreme N-terminal sequence of the P pro-
tein but excludes most of the TP and spacer region of the
P protein. As indicated in Fig. 1B, because the trans-
fected cell lysate was immunoprecipitated by anti-core
antiserum first and then denatured and reprecipitated
with antiserum against P6, this result also suggests that
this 43-kDa protein, like the full-length 90-kDa P protein,
should be associated with HBV core particles or core
proteins in cell lysate.
To study whether the HBV genome could produce the
43-kDa protein without transcomplementation with the
P-expressing plasmid containing the P gene, a PKA site
was engineered into pMH-9/3091 (Fig. 1A, Junker et al.,
1987), a plasmid which is colinear with the HBV pre-
genomic RNA generating the plasmid pMH-9/3091-II. As
shown in Fig. 1C, the production of the 43-kDa protein
was again found in the pMH-9/3091-II-transfected cell
(lane 11). On the contrary, the 43-kDa protein was not
detected in pMH-9/3091-transfected cells (lane 12), indi-
cating that the protein was specifically labeled at the
introduced PKA target site. In this experiment, the cell
lysates were directly precipitated with anti-P6 antiserum.
A similar result was obtained if the cell lysates were
precipitated with anti-core antiserum first and then re-
precipitated with anti-P6 antiserum (as in the experi-
ments conducted in lanes 1–10 of Fig. 1C). These results
strongly suggest that the 43-kDa protein should be nat-
urally produced in HBV-infected cells but not an artifact
of the P-expressing plasmid.
To determine whether the 43-kDa protein was pack-
aged into the secreted HBV particles, concentrated cul-
ture media from pMTP0II plus pMH-9/3091-m4-cotrans-
fected cells were subjected to cesium chloride (CsCl)
gradient centrifugation (as indicated in Fig. 1B, Huang et
al., 1996). Each fraction was monitored to detect the
amounts of HBsAg and HBc/eAg by enzyme-linked im-
munosorbent assay (ELISA, Huang et al., 1996) and HBV
viral DNA by endogenous polymerase activity assay (Fig.
2A). For detection of the total amount of the 43-kDa
protein, each fraction was boiled directly, immunopre-
cipitated with anti-P6 antiserum, and phosphorylated
with PKA and [g-32P]ATP. The distribution of the 43-kDa
proteins was found to be similar to the HBsAg profile and
copeaked with the 22-nm particles (Fig. 2A, fraction No.
14). However, when anti-P6 antiserum was used to di-
rectly precipitate the intact particles which were not
treated with detergent (Fig. 2C), similar amounts of the
43-kDa protein were detected from Dane particle-con-
taining fractions (pooled fractions of 11 and 12; lane 4)
and 22-nm HBsAg particles (fraction 14 on lane 6). En-
c
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401A NOVEL HBV STRUCTURAL PROTEINdogenous polymerase activity assay revealed that HBV
DNA was detected in fractions of naked cores and Dane
particles but not in fractions of 22-nm particles (Fig. 2B).
These results suggest that: (i) the 43-kDa protein is
present in Dane particles and 22-nm HBsAg particles; (ii)
a P6 epitope of the 43-kDa protein may be exposed on
FIG. 2. Association of 43-kDa proteins with secreted HBV viral parti
ells were separated by CsCl gradient centrifugation. (A) Profiles of HBs
nd HBc/eAg (gray diamond) were measured by ELISA. The value of P
bsorbancy value. Buoyant density (open circle, g/ml) was converted f
etected by HBV endogenous polymerase activity assay using ant
uantitated by a densitometer. The total amount of the 43-kDa protein (
nd 32P-phosphorylation and then was quantitated by a densitometer. (
(B) HBV viral DNA and (C) the 43-kDa protein were detected in thre
buffer-diluted fractions 7 and 8 were immunoprecipitated with normal se
particles in buffer-diluted fractions 11 and 12 or fraction 14 were immu
(aP6, lanes 4 and 6). After being washed, samples were divided into two
were treated with NP-40 and diluted, and the supernatants were reimm
activity assay was performed as described under Materials and Metho
2 in Fig. 2B. For detection of the 43-kDa proteins in (C), anti-P6 immuno
under Materials and Methods and in Fig. 1.the surface of these particles; (iii) similar to the LSprotein, the 43-kDa protein was enriched in Dane parti-
cles.
To determine the strength of the association between
the 43-kDa protein and HBV core particles, the secreted
HBV particles were first treated with 1% NP-40 to disrupt
22-nm HBsAg particles and remove envelopes from the
creted viral particles from pMTP0II- plus pMH-9/3091-m4-transfected
c/eAg, HBV DNA, and 43 kDa in a CsCl gradient. HBsAg (open square)
resents the sample absorbancy value divided by the negative control
refractive index. The amounts of HBV viral DNA (solid triangle) were
immunoprecipitates from the NP-40-treated fraction and then were
rcle) in each fraction was boiled and detected by immunoprecipitation
) Association analyses of the 43-kDa protein in various viral particles.
of HBV viral particles from CsCl fractions. Naked core particles in
RS, lane 1) or anti-core (aC, lane 2) antiserum. Dane particles or 22-nm
ipitated with normal serum (NRS, lanes 3 and 5) or anti-P6 antiserum
(B and C). For detection of viral DNA in (B), anti-P6-immunoprecipitates
ecipitated with anti-core antiserum and HBV endogenous polymerase
exposure time of lanes 3 to 6 is eightfold longer than in lanes 1 and
ates were boiled, reprecipitated, and 32P-phosphorylated as describedcles. Se
Ag, HB
/N rep
rom the
i-core
solid ci
B and C
e kinds
rum (N
noprec
parts
unopr
ds. The
precipitDane particles. The core particles were collected by
s
s
f
402 HUANG ET AL.ultracentrifugation through a 20% sucrose cusion and
treated with TNE buffer containing 0.25 to 2% SDS, fol-
lowed by immunoprecipitation with anti-core antiserum.
After reprecipitation with P6-antiserum and labeling with
PKA and [g-32P]ATP as described, our results indicate
that the association between the 43-kDa and HBV core
proteins was very strong based on the finding that the
association was stable even up to 1% SDS (Fig. 3). The
quantity of the 43-kDa protein and 90-kDa polymerase
was compared using a densitometer. We found that the
amount of the 43-kDa protein was about 10-fold higher
than that of the 90-kDa polymerase (Fig. 3, lane 1). Since
each virion was reported to contain one molecule of
polymerase (Bartenschlager and Schaller, 1992), the es-
timated number of the 43-kDa protein molecules on each
virion should be approximately 10. However, the actual
number of the 43-kDa protein molecules associated with
each virion may be higher, since the 43-kDa protein may
be present on the viral envelope in addition to that
associated with core particles.
The 43-kDa protein contains both P and preS-S
antigen epitopes
The fact that the 43-kDa protein can only be recog-
nized by P6 antiserum (reacted with amino acid residues
34 to 51 of P, Fig. 1A) but not by NX antiserum (reacted
with amino acid residues 40 to 372 of P) or by P8
antiserum (reacted with the last C-terminus sequence of
P) implied that the C-terminus of the 43-kDa protein was
likely encoded by other ORFs extrinsic of the P gene. To
test the possibility that the 43-kDa protein contains the
epitope of the surface protein, sequential immunopre-
FIG. 3. Characterization of the association between the 43-kDa and
HBV core proteins. The culture supernatant collected from pMTP0II-
plus pMH-9/3091-m4-transfected HuH-7 cells was treated with 1%
NP-40. The core particles were then collected by ultracentrifugation
through a 20% sucrose cusion and were dissolved in TNE buffer. After
treatment with various concentrations of SDS at room temperature for
30 min, samples were diluted with TNE buffer (final to 0.1% SDS) and
were immunoprecipitated with anti-core antiserum. After reprecipita-
tion with P6 antiserum and labeling with PKA and [g-32P]ATP as de-
cribed in the legend to Fig. 1C (lanes 1–10), immunoprecipitated
amples were analyzed by 10% SDS–PAGE. The positions of the 90-kDa
ull-length P protein and the 43-kDa protein are indicated.cipitation was performed on cell lysates from pMTP0- orpMTP0II-transfected HuH-7 cells which were immuno-
precipitated with goat anti-HBsAg antiserum or with P6
antiserum (Fig. 4A) and then reprecipitated with P6 or
goat anti-HBsAg antiserum. As shown in Fig. 4A, the goat
anti-HBsAg antiserum-precipitated 43-kDa protein could
be reprecipitated by P6 antiserum (lanes 2 and 4). In the
converse experiment, the 43-kDa protein first precipi-
tated by P6 antiserum could also be reprecipitated with
DAKO antiserum (lanes 10 and 12). The control experi-
ments showed that the 43-kDa protein could not be
detected from pMTP0-transfected HuH-7 lysates (lanes 5
to 8 and 13 to 16) nor precipitated by normal sera from
pMTP0II-transfected HuH-7 lysates (lanes 1, 3, 9, and 11).
The amount of the 43-kDa protein sequentially precipi-
tated by DAKO antiserum (lane 2) was much weaker than
that precipitated by DAKO followed by P6 antiserum (lane
FIG. 4. The 43-kDa protein contains both antigenic determinants of the
HBV P and S protein. (A) Characterization of the 43-kDa protein by immu-
nobiochemical assay. Lysates from pMTP0- or pMTP0II-transfected HuH-7
cells were first immunoprecipitated with DAKO (lanes 1 to 8) or P6 (lanes
9 to 16) antisera. Analysis procedures were performed as for Fig. 1B using
antisera as indicated at the top of the lanes. The loading amounts in lanes
10 and 12 were one-half and one-eighth. (B) Immunoreactivity of the
43-kDa protein with various HBV surface antisera. The 43-kDa protein was
first precipitated by anti-P6 antiserum. After being labeled with 32P and
boiled, the sample was aliquoted and reprecipitated with A10F1 (lane 2),
A/Y (lane 3), DAKO (lane 5), S1S2 (lane 7), P6 (lane 8), and control sera
(lanes 1, 4, and 6). The exposure time of lanes 1 to 3 is 10-fold longer than
that of lanes 4 to 8. All of the immunoprecipitates were subjected to 10%
SDS–PAGE and autoradiography.
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403A NOVEL HBV STRUCTURAL PROTEIN4). This discrepancy may arise from competition of the
43-kDa protein with a large amount of dissociated HB-
sAg. To sum up, the results suggest that the 43-kDa
protein contains epitopes of both P and S proteins.
To further understand whether the 43-kDa protein con-
tains domains of LS, MS, and SS protein, a panel of HBV
surface protein antisera was used to map the epitopes of
the S protein portion of the 43-kDa protein (Fig. 4B).
These antisera include the goat anti-HBsAg antiserum
(DAKO) that recognizes the whole denatured HBV sur-
face proteins including SS, MS, and LS protein; S1S2, a
rabbit antiserum that was raised against preS1–preS2
domains of the surface protein (Sheu and Lo, 1995); A10F1
monoclonal antibody that recognizes the SS domain; and
A/Y antiserum (Lee et al., 1984) that was shown to react
with the unglycosylated but not glycosylated form of SS
(data not shown). When the immunoprecipitates of the
pMTP0II-transfected cell lysates obtained with P6 anti-
serum were reprecipitated with these anti-HBsAg anti-
sera, the 43-kDa protein could be reprecipitated by
DAKO (lane 5), S1S2 (lane 7), A10F1 antisera (lane 2), and
A/Y antiserum (lane 3) (Fig. 4B). These results indicate
that the 43-kDa protein contains the epitopes of the
preS1–preS2 and SS region of the surface antigen. In-
terestingly, A/Y antiserum precipitated exclusively the
lower band of the 43-kDa doublet. This result explains
the possibility that the higher band of the 43-kDa doublet
might be a glycoprotein, a modification that was present
on surface proteins (Nassal, 1996).
The 43-kDa protein is a glycoprotein
To determine whether the 43-kDa protein is glycosy-
lated, the P6 antiserum-precipitated and 32P-labeled 43-
kDa protein was treated with endoglycosidase H
(EndoH) or peptide:N-glycosidase F (PNGaseF) to re-
move the N-linked oligosaccharide from the glycopro-
tein. As shown in Fig. 5A, the apparent molecular weight
of the 43-kDa protein (lanes 3 and 7) on SDS–PAGE was
shifted to 41 kDa after EndoH (lane 1) or PNGaseF (lane
5) treatment. A similar result was obtained from cells
treated with tunicamycin, a glycosylation inhibitor, as
demonstrated in Fig. 5B (lanes 2 and 4). Taken all to-
gether, these results indicate that the 43-kDa protein is
glycosylated.
The 43-kDa protein contains the C-terminal half
of the SS gene
To further confirm that the 43-kDa protein contains the
S ORF, the C-terminal half of the SS gene of pMTP0II was
deleted and replaced by a XbaI linker which contained a
stop codon at three different frames to generate
pMTP0IIDCS (Fig. 5C). As shown in Fig. 5C, the band
corresponding to the truncated P gene product (PDCS)
was now shifted from 90 to 50 kDa and the 43-kDa
doublet protein was shifted to approximately 33–31 kDa(lane 3; the 31-kDa protein in lane 4 was the unglycosy-
lated form of P-SDCS). We obtained the similar conclu-
sion from another pre-S1 deletion mutant pMTP0IIDBE
(nt 2904–1, Radziwell et al., 1990). In conclusion, these
results provide strong evidence that the 43-kDa protein
contains the pre-S to the carboxyl terminal half region of
the SS gene.
The 43-kDa protein is encoded by a HBV spliced RNA
characterized by joining the P ORF to the S ORF
Immunochemical analyses of the 43-kDa protein re-
vealed that it contains both the antigenic determinants of
the polymerase and the surface protein. A possible
mechanism to account for the origin of the 43-kDa pro-
tein is that it may be encoded by a spliced RNA charac-
terized by the adjoining P and S genes. Therefore, re-
erse transcriptase-polymerase chain reaction (RT-PCR)
nalysis was conducted to test for the possibility of the
xistence of a spliced transcript. Immunochemical anal-
ses suggest that the 43-kDa protein should be initiated
rom the initiation codon of P and immediately fused to
he surface protein ORF. Thus, two primers were de-
igned to amplify the DNA fragment that covered the
utative spliced junction as depicted in Fig. 6A. The
ense primer P1 was close to the initiation site of the P
rotein and the antisense primer P2 was located at the
S region. The previously reported single or double
pliced RNA (Chen et al., 1989; Gu¨nther et al., 1997; Su et
al., 1989; Suzuki et al., 1989, 1990; and Terre´ et al., 1991)
would not be amplified by these primers because the
primers P1 and P2 were within the intron region of these
spliced RNAs. The RNA isolated from pSHH2.1- (Chang
et al., 1987) and pMH-9/3091-transfected cells was sub-
jected to RT-PCR using these two primers. In addition to
the 1.0-kb product corresponding to the unspliced-pre-
genomic RNA, a new 0.6-kb PCR product was clearly
amplified by these primers in samples from pSHH2.1-,
pMH-9/3091-, and pMTP0-transfected cells (data not
shown). Both the 1.0- and the 0.6-kb bands were not
detected in samples from untransfected cells. These
0.6-kb products were cloned into the pT-Adv vector and
sequenced. It was found that the sequence of HBV at nt
2902 was now joined to nt 2447, skipping 454 nts, as
demonstrated in Fig. 6B. The same deletion was found in
cDNA from a hepatocellular carcinoma cell line, PLC/
PRF/5 (Ziemer et al., 1985). Deduced amino acids se-
quence of the 0.6-kb product revealed that the 47th
amino acid of the P protein was fused to the 19th amino
acid of the LS protein. Sequence alignment showed the
presence of consensus splice donor and acceptor sites
at junctions (Fig. 6B). Furthermore, these splicing donor
and acceptor sites were conserved among various sub-
types of HBV (Fig. 6C). To examine whether the newly
identified HBV spliced RNA contained spliced regions
other than 2447/2902, primers near the 59 or 39 ends of
H
b nally su
404 HUANG ET AL.the HBV pregenomic RNA and primers containing the
2447/2902 splice junction were used. For the mapping of
the 59-end, we used a reverse primer harboring the
junction sequences of 2447/2902 paired with a primer of
the very 59-end of pregenomic RNA. The sequencing
analysis revealed that a single band was amplified and
FIG. 5. The analysis of glycosylation of the 43-kDa protein. (A) Glycosy
antiserum and 32P-labeling, samples were denatured, equally divided, and
no enzymes (2, lanes 3, 4, 7, and 8). (B) The analysis of glycosylation of th
posttransfection were treated with 20 mg/ml tunicamycin (lanes 2 and 3)
protein was obtained and analyzed essentially as for Fig. 1C (lanes 11 and
of the deletion regions of construct pMTP0IIDCS. Anti-P6 immunoprecipit
uH-7 cell lysates were treated with PNGaseF (lanes 2 and 4) or with no e
y PDCS or P-SDCS. All of the immunoprecipitates from (A) to (C) were fithere was no spliced region (data not shown). To explorethe 39-end of this splice RNA, we used a splicing junction
2447/2902 containing primer and reverse primer near the
39-end of the HBV genome. Two PCR products were
found. One product contained no other deletion and the
other had a deletion at nts 2985 to 489. These results
indicate that the transfected HuH-7 cells produce two
nalysis of the 43-kDa protein in vitro. Following precipitation with anti-P6
ted with endoH (lanes 1 and 2) or with PNGaseF (lanes 5 and 6) or with
a protein in vivo. pMTP0- or pMTP0III-transfected HuH-7 cells at 2 days
l volumes of 50% EtOH (as negative control; lanes 4 and 5). The 43-kDa
) Deletion analysis of the 43-kDa protein. (Top) Schematic representation
m pMTP0II- (lanes 1 and 2) or pMTP0IIDCS- (lanes 3 and 4) transfected
(2, lanes 1 and 3). The truncated P proteins or P–S proteins are indicated
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405A NOVEL HBV STRUCTURAL PROTEINof 2447 to 2902 and the other containing a double spliced
region of 2985 to 489, in addition to the 2447 to 2902.
Since the latter RNA cannot be amplified by our reverse
primer P2 (nts 120 to 139) and the 43-kDa protein has
epitopes of pre-S and SS domains of the surface protein
(Figs. 4B and 5C), the 43-kDa protein could not possibly
be encoded by such doubly spliced RNA. To sum up,
FIG. 6. Cloning and characterization of a novel spliced cDNA. (A) Dia
tudy. HBV gene organization and the nucleotide sequences correspon
published single (Su et al., 1989) and double spliced RNAs (Chen et
utative splice RNAs. Arrows stand for primers (P1 and P2) and the nu
unction of single and double splicing RNAs are also indicated. The da
nalysis of the spliced cDNA. The cDNA was amplified by RT-PCR from
loned into the pT-Adv vector. Clones that contain putative spliced cD
plice junction are indicated. (Bottom) RNA alignment analysis of the s
ertical arrows indicate the splice donor and acceptor sites. The bla
epresent exons. The spliced junction and its deduced amino acids a
cceptor site sequences between four subtypes of HBV. (D) The pr
dinucleotides of the splice acceptor site in the wild-type pMTP0II were
mutated nucleotide is underlined). The analysis of the 43-kDa proteinthese results suggest that a HBV RNA, with a singlesplice at nts 2447 to 2902, should be the mRNA encoding
for the 43-kDa protein.
To substantiate the finding that the 43-kDa protein is
encoded by a spliced RNA as described above, the
conserved nucleotide at nt 2902 in the splice acceptor
site of pMTP0II was changed from A to C to generate the
construct pMTP0IImSA. This mutation should result in a
f the putative spliced RNA and the positions of the primers used in this
their 59 and 39 ends of individual genes are indicated at the top. The
9) are illustrated in the middle. The spliced P–S RNA represents the
e number of both the 59-end and the 39-end of primers as well as the
ine represents the introns. (B) Sequence determination and alignment
NAs of pMH-9/3091- or pMTP0-transfected cells. PCR fragments were
ments were sequenced. The positions (arrow) and sequences of the
onsensus sequence (top) and pregenomic sequence of HBV (middle).
with arrows plus the sequences up or down to the vertical arrows
ated at the bottom. (C) Sequence alignment at the splice donor and
n of the 43-kDa protein by mutation analysis. (Top) Conserved AG
d to CG, resulting in the generation of the plasmid of pMTP0IImSA (the
rformed as in Fig. 1C.gram o
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406 HUANG ET AL.full-length P protein was clearly expressed in the
pMTP0II- (lane P0II) and pMTP0IImSA- (lane P0IImSA)
transfected cells. However, the production of the 43-kDa
protein was abrogated in pMTP0IImSA compared to the
wild type (pMTP0II). A similar result was obtained when
the conserved splice donor site at nt 2446 was mutated
from A to C (data not shown). Furthermore, using [35S]me-
thionine (Met) in vivo labeling and immunoprecipitation,
e detected a 43-kDa doublet protein from pMTP0sp-
the spliced cDNA was cloned into plasmid pMTP0)
ransfected cells. Like the 32P-labeled P–S protein, this
[35S]Met doublet protein was also precipitated with
nti-P6 antiserum and reprecipitated by anti-surface an-
iserum (data not shown). Therefore, we conclude that
he 43-kDa protein is encoded by this single spliced
NA.
he 43-kDa P–S fusion protein is able to substitute
or the LS protein in virion maturation
The P–S fusion protein containing the majority of the
S protein and N-terminal truncation up to residue 91
subtype ayw) of the LS protein still allowed virion secre-
ion (Bruss et al., 1994); therefore, we examined whether
he P–S fusion protein was able to substitute for the
unction of the LS protein in virion maturation. To gener-
te the LS amber mutant plasmid (pMH-9/3091LS2), the
TG start codon of LS in pMH-9/3091 was converted to
ACG. This mutation did not alter the amino acid se-
quence of polymerase (Ueda et al., 1991). A P–S fusion
protein expressing plasmid, pMTP0sp, was constructed
by replacing the fragment of pMTP0 with 2447/2902
spliced cDNA. To examine virion production, collected
particles from the culture media of cells transfected with
pMH-9/3091 or pMH-9/3091LS2 or cells cotransfected
ith pMH-9/3091LS2 and pMTP0sp (4:1) were subjected
o CsCl gradient fractionation and the HBV viral DNA in
ach fraction was monitored by HBV endogenous poly-
erase activity assay. As reported previously (Gerel-
aikhan et al., 1996), viral particles from the wild-type
genome could be separated into naked core particles
(labeled with naked) and Dane particles (labeled with
Dane) as shown in Fig. 7A. Loss of LS protein expression
failed to produce virions (Bruss et al., 1994) (Fig. 7B,
fractions 9–11, a density of about 1.26 to 1.238 g/ml), but
these transfected cells still could produce naked nucleo-
capsids (fractions 3 to 6, a density of about 1.36 to 1.314
g/ml). Upon cotransfection with P–S fusion protein ex-
pressing plasmid pMTP0sp, particles containing HBV
DNA with a density of about 1.248 to 1.234 were rescued
(Fig. 7C, fractions 9–11). Reproducible results were also
obtained using immunoprecipitation methods to purify
Dane particles by antiserum against HBsAg (data not
shown; methods as described in Gerelsaikhan et al.,
1996; and Huang et al., 1996). In summing up the above,
these data indicate that the 43-kDa P–S fusion proteinsare present in Dane particles and are able to substitute
for the LS protein in virion maturation.
Although there are many HBV spliced RNAs which
have been identified (Chen et al., 1989; Gu¨nther et al.,
1997; Su et al., 1989; Suzuki et al., 1989, 1990; and Terre´
et al., 1991); only one of their protein products has been
reported, i.e., the 10-kDa protein (Soussan et al., 2000).
This 10-kDa protein was translated from the first charac-
terized singly spliced RNA (Su et al., 1989). Apparently, it
was reported not to be involved in the regulation of viral
transcription and replication; however, this protein could
induce apoptosis in transfected cells. Our results show
that another protein, a polymerase/surface fusion glyco-
protein, is encoded by a spliced RNA. The glycoprotein
was demonstrated to be a structural protein of Dane
particles and 22-nm subviral particles. Each virion was
estimated to contain about 10 molecules of the 43-kDa
protein. Since 40 to 80 LS molecules were reported to be
present in each virion (Heermann et al., 1984), the num-
ber of the 43-kDa protein molecules per HBV virion is
approximately one-fourth to one-eighth that of the LS
protein. It is interesting to note that the P–S protein was
detected in membrane-containing viral particles, 42-nm
Dane particles, and 22-nm subviral particles, but not in
naked core particles or culture medium (Fig. 2). However,
the P–S protein does interact with core protein inside
cells (Fig. 1). We do not know the mechanism by which
naked core particles are transported outside of the cells.
Probably, core particles that are destined to depart from
the cells (as naked core particles) are sequestered in an
environment where interaction with the P–S protein is
not permissible. On the contrary, membrane-containing
particles can readily interact with surface proteins, in-
cluding the P–S protein, on the exterior of the endoplas-
mic reticulum before assembling into mature viruses.
The interaction could not be dissociated when cells were
lysed with NP-40 or during CsCl gradient centrifugation.
This explanation may account for the discrepancy that
the P–S protein can interact with the core protein within
the cell, but cannot associate with naked core particles.
Similar to our 43-kDa protein, an L protein of DHBV
was recently reported by Obert et al. (1996). This L
protein of DHBV is also encoded by a spliced RNA
derived from the pregenomic RNA of DHBV. The L protein
is identical to the DHBV envelope protein but with addi-
tional function in controlling a distinct role in an early
stage of the viral life cycle. Structurally, the 43-kDa pro-
tein is similar to the L protein with the exception that the
N-terminus of the LS protein is replaced by the first 47
amino acids of the N-terminus of the P protein. This
replacement leads to the loss of the myristylation site, a
site for posttranslational modification at the extreme N-
terminus of the LS protein. Similar to the 10-kDa protein
of HBV and the L protein of DHBV, the 43-kDa protein had
no effect on viral replication in HuH-7 cells transfected
with pMH-9/3091mSA mutant plasmid (data not shown).
407A NOVEL HBV STRUCTURAL PROTEINUnlike the DHBV, an animal or in vitro infection model for
HBV is not readily available to test whether the 43-kDa
protein plays a role in the HBV life cycle. Therefore, the
possibility that the 43-kDa proteins may be merely
present in HBV Dane and 22-nm subviral particles with-
out biological functions cannot be completely ruled out.
Despite the difficulty, our studies clearly demonstrated
that the 43-kDa protein could substitute for the LS protein
for HBV maturation (Fig. 7). More importantly, many char-
acteristics were found to be similar between both the LS
protein and the P–S protein. First, since our 43-kDa
protein was able to interact with the core proteins in the
cell lysate (Fig. 1 and data not shown), it resembles the
interaction between the LS and the core protein as dem-
onstrated previously (Dyson and Murray, 1995; Poisson
et al., 1997). Furthermore, the interacting domains of both
the LS and the 43-kDa protein were mapped to the
pre-S1 region (nts 2904 to 1 for the P–S protein) (data not
shown; Dyson and Murray, 1995). These results may
FIG. 7. The 43-kDa P–S protein is able to substitute for the LS protein
from pMH-9/3091- (top), pMH-9/3091LS2- (middle), or pMH-9/3091LS2
particles and virions were detected by endogenous polymerase activi
lane. The relaxed circular form (RC) and linear form (L) are indicated on
particles (Dane) are indicated at the top.account for why the 43-kDa protein is able to substitutefor the LS protein in virion formation. Second, like the LS
protein, the 43-kDa P–S protein was relatively more en-
riched in Dane particles than in 22-nm HBsAg particles
(Fig. 1 and Nassal, 1996). Finally, previous results have
demonstrated the possibility that the LS proteins of HBV
interact with their receptors on hepatocytes (Pontisso et
al., 1989). The high degree of homology between the
43-kDa protein and the LS protein of HBV suggests that
the 43-kDa protein may also be involved in the entry of
HBV to hepatocytes.
MATERIALS AND METHODS
Cell culture, transfection, and preparation of cell
lysate or secreted viral particles
HuH-7 cells were grown at 37°C in Dulbecco’s modi-
fied Eagles’ medium supplemented with 10% fetal calf
serum, 100 IU/ml penicillin, 100 mg/ml streptomycin, 2
mM L-glutamine, 1% nonessential amino acid, and 25
n formation. After CsCl density gradient fractionation of cultural media
MTPosp- (4:1) (bottom) transfected cells, DNA contents in naked viral
y as in Fig. 2A. Fraction numbers (Fr #) are shown at the top of each
ht side, and the fractions contain naked core particles (naked) or Danein virio
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408 HUANG ET AL.plasmid DNA (20 mg of each plasmid for cotransfection)
was used to transfect 1 3 107 cells/150-mm petri dish by
he calcium phosphate coprecipitation method as de-
cribed previously (Chang et al., 1987). Three days post-
ransfection, cells were harvested and lysed with NET
uffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM
DTA, 0.5% Nonidet P-40 [NP-40]) containing 1 mM phe-
ylmethylsulfonyl fluoride (Sigma, St. Louis, MO), 2 mg/ml
eupeptin, and 2 mg/ml aprotinin (Boehringer Mannheim,
Germany). Then the cell lysates were clarified by centrif-
ugation (17,000g, 4°C, Sigma 2K15) before immunopre-
cipitation. Secreted viral particles from the culture fluid of
transfected HuH-7 cells were precleared and concen-
trated by ultracentrifugation at 180,000g for 3 h as de-
scribed previously (Huang et al., 1996). Finally, the pellets
were dissolved in TNE buffer (10 mM Tris–HCl, pH 7.4,
100 mM NaCl, 1 mM EDTA).
Plasmid constructions
Standard methods were used for plasmid construction
(Sambrook et al., 1989). The mutated sequences were
generated by site-directed mutagenesis (Promega, Mad-
ison, WI) or a standard jumping PCR procedure and then
were confirmed by sequencing using the dideoxy termi-
nation method (Sanger et al., 1977).
In this study, the unique EcoRI site on the HBV genome
(ayw subtype) was numbered nucleotide 1. Plasmid
pMH-9/3091 contains an overlength HBV genome, which
is under the control of the human metallothionein pro-
moter (Junker et al., 1987). The polymerase defective
mutant, pMH-9/3091-m4, was used for complementing
core proteins in the cotransfection system (Chiang et al.,
1990). The polymerase expression plasmid, pMTP0, was
generated by deletion of the HindIII–AluI (nt 2291) frag-
ment of pMH3/3097 by multiple steps. First, the AluI
fragment (nts 2291 to 2992) of pMH3/3097 was inserted
into the HindIII site located in front of the HBV sequence
on the same plasmid. The resulting plasmid was di-
gested with BspMII (nt 2330) followed by self-ligation.
The upstream flanking sequence of the initiation codon
was changed to CGCATG (to create a Kozak sequence)
according to the manual of the pSELECT-1 site-directed
mutagenesis kit (Promega) using an oligonucleotide of
59-GCTTATAGACCACCGCATGCCCCTATCCT-39 (nt 2291
to 2319). To construct the polymerase containing the
protein kinase A targeting sequence, the oligonucleo-
tides containing the PKA consensus sequences were
introduced into pMTP0 by site-directed mutagenesis as
described above. The oligonucleotide, 59-1512-CGAC-
CGACCACGCGTCGCACCTCTCTT-1538-39, was used to
generate pMTP0I; pMTP0II was produced by the oligo-
nucleotide 59-2325-CACTTCCGGAGACTATCGATGTTAG-
ACGACGAGG-2358-39; pMTP0III was generated to con-
ain both PKA targeting sites on the P gene using both
ligonucleotides. For generation of pMH-9/3091-II, a PKA etarget site from pMTP0II was engineered into pMH-9/
3091 by replacing the BspMII to MunI (nts 2330 to 2629)
fragment of pMTP0II. To generate the construct
pMTP0IImSA, the conserved splice acceptor site at nt
2900 was changed from A to C by site-directed mutagen-
esis with the oligonucleotide 59-2890-TTCCCGACCAC-
CCGTTGGATCCAGC-2914-39. All of the oligonucleotides
in which the sequences mismatch to the wild-type se-
quence are underlined. pMTP0IIDCS was constructed by
replacement of the BamHI–BamHI (nts 490–1402) frag-
ment of pMTP0II with the XbaI linker which contains a
stop codon at three different frames (Stratagene, La Jolla,
CA). A P–S fusion protein expressing plasmid, pMTP0sp,
was constructed by replacing the BglII to EcoRI (nts 2424
to 1) fragment of pMTP0 from the 2447/2902 spliced
cDNA. To generate the LS amber mutant plasmid pMH-
9/3091LS2, the ATG start codon of LS in pMH-9/3091 was
converted to ACG with the oligonucleotide 59-2839-ATC-
TACAGCACGGGGCAGAATCTT-2862-39 by a standard
jumping PCR procedure.
Antisera
Anti-P6 is a rabbit serum which was generated by the
peptide (amino acid residues 34 to 51) of the polymerase
(Bartenschlager et al., 1992). NX antisera were generated
by several injections using SDS–PAGE-purified glutathi-
one S-transferase-fused P fragment that corresponds to
the amino acid residues of 40 to 372 of the polymerase
(Lin et al., 1993). A10F1 and A/Y surface monoclonal
antibodies were kindly provided by Dr. Lee (Lee et al.,
1984). DAKO is a goat polyclonal antiserum against the
surface protein that was purchased from DAKO Com-
pany (DAKO Corp., Carpinteria, CA). S1S2 is a rabbit
polyclonal antiserum against pre-S1–pre-S2 domains of
the surface protein (Sheu and Lo, 1995). Rabbit anti-
serum against the core protein was generated by injec-
tions of HBV core proteins expressed from Escherichia
coli.
Immunoprecipitation and radioactive labeling
of proteins with PKA
The precleared cell lysates or the concentrated culture
media were reacted with protein A Sepharose coated
with antibodies against polymerase or surface protein
(see Fig. 1B and text). After several washings with NET
buffer or RIPA buffer (phosphate-buffered saline contain-
ing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1%
SDS) and PKA buffer (20 mM Tris–HCl, pH 7.0, 100 mM
NaCl, 10 mM MgCl2), the immunoprecipitates were phos-
phorylated by PKA using [g-32P]ATP (New England Nu-
lear, Boston, MA) as substrate (Bartenschlager et al.,
992). The phosphorylated immunoprecipitates were
ashed with PBS and boiled with sample buffer (200 mM
ris–HCl, pH 8.0, 5 mM EDTA, 2% SDS, 1% 2-mercapto-
thanol [2-ME], 10% sucrose, and 0.1% bromophenol
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reimmunoprecipitated with specific anti-polymerase an-
tiserum. Finally, the immunoprecipitates were boiled in
sample buffer and subjected to 10% SDS–PAGE and
autoradiography. For analysis of the core-associated
polymerase or the P–S protein, the cell lysates or con-
centrated culture media were first reacted with rabbit
antiserum against the core protein. They were then
washed, boiled, and reprecipitated with antisera against
polymerase as described above.
Separation of HBV particles by cesium chloride
gradients
Concentrated viral particles were mixed with 10 ml of
CsCl solution (final concentration 1.24 g/ml) and centri-
fuged at 150,000g for 44 h in a Beckman SW41 rotor
(Huang et al., 1996). Four hundred microliters of each
fraction was collected from the bottom of the tubes and
the density was determined with a refractometer. Surface
and HBV c/e antigens were determined by ELISA (Huang
et al., 1996). In Figs. 2B and 2C, pooled fractions were
diluted with TNE buffer and were immunoprecipitated
with anti-P6 antiserum to further purify the Dane particles
and 22-nm HBsAg particles. For detection of the 43-kDa
protein (Fig. 2C), the immunoprecipitates were boiled,
diluted, and reprecipitated with anti-P6 antiserum and
phosphorylated as described above. For detection of the
HBV DNA in Dane particles in Fig. 2B, the anti-P6 immu-
noprecipitates were treated with TNE buffer containing
2% NP-40 to release the viral nucleocapsids (Huang et
al., 1996) and diluted with TNE buffer, and then the
supernatants were immunoprecipitated with antiserum
against the core proteins. After several washes, the sam-
ples were subjected to HBV endogenous polymerase
activity assay.
HBV endogenous polymerase activity assay
In Figs. 2A and 7, CsCl fractions were directly treated
with TNE buffer containing 2% NP-40 and then diluted
and immunoprecipitated with rabbit antiserum against
the core. After being washed, immunoprecipitates were
incubated in polymerase buffer (50 mM Tris–HCl, pH 7.5,
40 mM NH4Cl, 10 mM MgCl2, 1% NP-40, 2% 2-ME, 12.5
mM each dATP, dGTP, dTTP, 80 mCi [a32P]dCTP (5000
Ci/mmol), for 3 h at 37°C (Chang et al., 1987; Kaplan et
al., 1973). The unlabeled dCTP (12.5 mM) was then added
or filling the remaining gaps. After incubation and wash-
ngs, proteinase K (200 mg/ml, Merck, Germany) and SDS
0.5%) were added for 2 h at 37°C. Then labeled HBV
NA were extracted and subjected to 1.2% agarose gel
lectrophoresis and autoradiography.
lycosylation analyses
The transfected HuH-7 cells at 2 days posttransfection
ere treated with 20 mg/ml tunicamycin (in 50% ethyl Blcohol (EtOH]) or 50% EtOH (as negative control) for 16 h
t 37°C (Huang et al., 1996); cells were then harvested.
he P–S protein was immunoprecipitated and labeled
ith 32P as described above. For the treatment of EndoH
r PNGaseF, the first anti-P6 immunoprecipitates were
ivided into two parts and boiled in 13 denaturation
uffer (0.5% SDS, 1% b-mercaptoethanol) for 10 min fol-
lowed by reacting with 50 units EndoH or PNGaseF (New
England Biolabs, Beverly, MA) or without treatment at
37°C for 60 min in 13 G5 buffer (50 mM sodium citrate,
pH 5.5) or 13 G7 buffer (50 mM sodium phosphate, pH
5.5) containing 1% NP-40 according to the manufacturer’s
manual. After being boiled, reaction mixtures were re-
precipitated with anti-P6 antiserum.
RNA extraction and RT-PCR analysis
Total cellular RNA was isolated from transfected or
untransfected cells by the Ultraspec-II RNA isolation kit
(Biotecx, Houston, TX) as described in the manufactur-
er’s manual. Five micrograms of total RNA was used for
first-strand cDNA synthesis using oligo-dT as a primer.
One-fiftieth of the cDNA products was subjected to poly-
merase chain reaction using P1 (59-CCCCTATCCTAT-
CAACACTT-39, nts 2310 to 2329) and the antisense P2
(59-CAATCCTCGAGAAGATTGAC-39, nts 120 to 139) as
primers and Taq DNA polymerase (Boehringer Mann-
heim, Germany) for 35 cycles at 94°C for 1 min, 57°C for
1 min, and 72°C for 1.5 min in a Perkin–Elmer thermocy-
cler 9600. The 0.6-kb PCR products were purified and
cloned into the pT-Adv vector (Clontech, Palo Alto, CA),
according to the instructions of the manufacturer. The
sequences were determined by the dideoxy termination
method (Sanger et al., 1977).
ACKNOWLEDGMENTS
We thank H.-J. Kung, H.-H. Liu, and B. Wang for critical reading and
helpful suggestions in the writing of the manuscript; S.-C. Lee for
providing the anti-HBsAg antisera; and C.-M. Tseng, S.-J. Shieh, R.-I.
Chen, and Y.-C. Chou for experimental assistance. This work was
supported by grants from the Department of Intramural Research Af-
fairs, National Health Research Institutes and National Science Coun-
cil, in the Republic of China (NSC 86-2314-B-010-040 and NSC 87-2314-
B-010-075).
REFERENCES
Bartenschlager, R., Kuhn, C., and Schaller, H. (1992). Expression of the
P-protein of the human hepatitis B virus in a vaccinia virus system
and detection of the nucleocapsid-associated P-gene product by
radiolabelling at newly introduced phosphorylation sites. Nucleic
Acids Res. 20, 195–202.
Bartenschlager, R., and Schaller, H. (1992). Hepadnaviral assembly is
initiated by polymerase binding to the encapsidation signal in the
viral RNA genome. EMBO J. 11, 3413–3420.
russ, V., Lu, X., Thomssen, R., and Gerlich, W. H. (1994). Post-transla-
tional alterations in transmembrane topology of the hepatitis B virus
large envelope protein. EMBO J. 13, 2273–2279.russ, V., and Thomssen, R. (1994). Mapping a region of the large
410 HUANG ET AL.envelope protein required for hepatitis B virion maturation. J. Virol.
68, 1643–1650.
Chang, C., Jeng, K. S., Hu, C., Lo, S. J., Su, T. S., Ting, L. P., Chou, C. K.,
Han, S. H., Pfaff, E., Salfeld, J., and Schaller, H. (1987). Production of
hepatitis B virus in vitro by transient expression of cloned HBV DNA
in a hepatoma cell line. EMBO J. 6, 675–680.
Chen, P. J., Chen, C. R., Sung, J. L., and Chen, D. S. (1989). Identification
of a doubly spliced viral transcript joining the separated domains for
putative protease and reverse transcriptase of hepatitis B virus.
J. Virol. 63, 4165–4171.
Chiang, P. W., Hu, C., Su, T. S., Lo, S. J., Chu, M. H., Schaller, H., and
Chang, C. (1990). Encapsidation of truncated human hepatitis B virus
genomes through trans-complementation of the core protein and
polymerase. Virology 176, 355–361.
Dyson, M. R., and Murray, K. (1995). Selection of peptide inhibitors of
interactions involved in complex protein assemblies: Association of
the core and surface antigens of hepatitis B virus. Proc. Natl. Acad.
Sci. USA 92, 2194–2198.
Ganem, D. (1996). Hepadnaviridae and their replication. In “Fields
Virology” (B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L.
Melnick, T. P. Monath, B. Roizman, and S. E. Straus, Eds.), 3rd ed., Vol.
2, pp. 2703–2737. Lippincott–Raven, Philadelphia, PA.
Gerelsaikhan, T., Tavis, J. E., and Bruss, V. (1996). Hepatitis B virus
nucleocapsid envelopment does not occur without genomic DNA
synthesis. J. Virol. 70, 4269–4274.
Gu¨nther, S., Sommer, G., Iwanska, A., and Will, H. (1997). Heterogeneity
and common features of defective hepatitis B virus genomes derived
from spliced pregenomic RNA. Virology 238, 363–371.
Heermann, K. H., and Gerlich, W. H. (1991). Surface proteins of hepatitis
B viruses. In “Molecular Biology of the Hepatitis B Virus” (A.
McLachlan, Ed.), pp. 109–143. CRC Press, Boca Raton, FL.
Heermann, K. H., Goldmann, U., Schwartz, W., Seyffarth, T., Baumgarten,
H., and Gerlich, M. H. (1984). Large surface proteins of hepatitis B
virus containing the pre-S sequence. J. Virol. 52, 396–402.
Huang, R. L., Chen, C. C., Huang, Y. L., Hsieh, D. J., Hu, C., Chen, C. F.,
and Chang, C. (1996). Osthole increases glycosylation of hepatitis B
surface antigen and suppresses the secretion of hepatitis B virus in
vitro. Hepatology 24, 508–515.
Junker, M., Galle, P., and Schaller, H. (1987). Expression and replication
of the hepatitis B virus genome under foreign promoter control.
Nucleic Acids Res. 15, 10117–10132.
Kaplan, P. M., Greenman, R. L., Gerin, J. L., Purcell, R. H., and Robinson,
W. S. (1973). DNA polymerase associated with human hepatitis B
antigen. J. Virol. 12, 995–1005.
LeSeyec, J., Chouteau, P., Cannie, I., Guguen-Guillouzo, C., and Gripon,
P. (1998). Role of the pre-S2 domain of the large envelope protein in
hepatitis B virus assembly and infectivity. J. Virol. 72, 5573–5578.
Lee, S. C., Shew, J. Y., and Chang, A. C. H. (1984). Monoclonal antibod-
ies to hepatitis B surface antigen (HBsAg) produced by somatic cell
hybrids. J. Formos. Med. Assoc. 83, 142–148.
Li, B. L., Langer, J., Schwartz, B., and Pestka, S. (1989). Creation of
phosphorylation sites in proteins: Construction of a phosphorylat-
able human interferon alpha. Proc. Natl. Acad. Sci. USA 86, 558–562.
Lin, C., You, L., and Lo, S. J. (1993). Expression and stability of the
hepatitis B pol protein in Escherichia coli. J. Gastro. Hepatol. 8,
S54–58.Nassal, M. (1996). Hepatitis B virus morphogenesis. Curr. Top. Micro-
biol. Immunol. 214, 297–337.
Nassal, M., and Schaller, H. (1993). Hepatitis B virus replication. Trends
Microbiol. 221, 211–228.
Nassal, M., and Schaller, H. (1996). Hepatitis B virus replication—An
update. J. Viral. Hepatol. 3, 217–226.
Obert, S., Zachmann-Brand, B., Deindl, E., Tucker, W., Bartenschlager,
R., and Schaller, H. (1996). A spliced hepadnavirus RNA that is
essential for virus replication. EMBO J. 15, 2565–2574.
Poisson, F., Severac, A., Hourioux, C., Goudeau, A., and Roingeard, P.
(1997). Both pre-S1 and S domains of hepatitis B virus envelope
proteins interact with the core particle. Virology 228, 115–120.
Pontisso, P., Petit, M. A., Bankowski, M. J., and Peeples, M. E. (1989).
Human liver plasma membranes contain receptors for the hepatitis B
virus pre-S1 region and via polymerized human serum albumin for
the pre-S2 region. J. Virol. 63, 1981–1988.
Radziwill, G., Tucker, W., and Schaller, H. (1990). Mutational analysis of
the hepatitis B virus P gene product: Domain structure and RNase H
activity. J. Virol. 64, 613–620.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). “Molecular Cloning:
A Laboratory Manual,” 2nd ed. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY.
Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with
chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 75, 5463–
5467.
Sheu, S. Y., and Lo, S. J. (1995). Deletion or alteration of hydrophobic
amino acids at the first and the third transmembrane domains of
hepatitis B surface antigen enhances its production in Escherichia
coli. Gene 160, 179–184.
Soussan, P., Garreau, F., Zylberberg, H., Ferray, C., Brechot, C., and
Kremsdorf, D. (2000). In vivo expression of a new hepatitis B virus
protein encoded by a spliced RNA. J. Clin. Invest. 105, 55–60.
Su, T. S., Lai, C. J., Huang, J. L., Lin, L. H., Yauk, Y. K., Chang, C., Lo, S. J.,
and Han, S. H. (1989). Hepatitis B virus transcripts produced by RNA
splicing. J. Virol. 63, 4011–4018.
Suzuki, T., Masui, N., Kazunori, K., Saito, I., and Miyamura, T. (1989).
Detection and mapping of spliced RNA from a human hepatoma cell
line transfected with the hepatitis B virus genome. Proc. Natl. Acad.
Sci. USA 86, 8422–8426.
Suzuki, T., Kajino, K., Masui, N., Saito, I., and Miyamura, T. (1990).
Alternative splicing of hepatitis B virus RNAs in HepG2 cells trans-
fected with the viral DNA. Virology 179, 881–885.
Terre´, S., Petit, M. A., and Brechot, C. (1991). Defective hepatitis B virus
particles are generated by packaging and reverse transcription of
spliced viral RNAs in vivo. J. Virol. 65, 5539–5543.
Ueda, K., Tsurimoto, T., and Matsubara, K. (1991). Three envelope
proteins of hepatitis B virus: Large S, middle S, and major S
proteins needed for the formation of Dane particles. J. Virol. 65,
3521–3529.
Vaishnav, Y. N., and Wong-Staal, F. (1991). The biochemistry of AIDS.
Annu. Rev. Biochem. 60, 577–630.
Ziemer, M., Garcia, P., Shaul, Y., and Rutter, W. J. (1985). Sequence of
hepatitis B virus DNA incorporated into the genome of a human
hepatoma cell line. J. Virol. 53, 885–892.
